Atlas Trials

A Study of HIPEC Plus Apatinib and S-1 Conversion Therapy for Gastric Cancer With Positive Exfoliative Cancer Cells

Clinical trial NCT03428425 · UNKNOWN

Trial details

NCT number
NCT03428425
Sponsor
Hebei Medical University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Gastric Cancer
Start date
2018-02-01
Primary completion
2018-12-01
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.